-The Hindu ‘But cumbersome anti-graft apparatus can delay decisions'   With a slew of scams vitiating the government's policy-making environment and holding up reforms, the Economic Survey 2011-12 on Thursday advocated need for a ruthless crackdown on corruption, but cautioned that a large and cumbersome anti-corruption bureaucracy could impact decision-making. “While we need to ruthlessly crack down on corruption, it must, at the same time, be recognised that the fear of a large and...

-The Telegraph The economic survey has challenged an international assessment that has ranked India 125, or near-bottom, among 132 countries on environmental performance, but has acknowledged that air pollution has increased to alarming levels. The survey, released by the Union government today, has questioned the methodology of the Environmental Performance Index 2012 that has assigned air quality in India a rank of 132, the worst in the world, and similarly low ranks...

-PTI Budget allocation for central government hospitals in the capital has been increased for the coming fiscal, with AIIMS getting Rs 1,124 crore which is nearly 6% more as compared to the last year's Rs 1,062.35 crore. This is followed by the Safdarjung Hospital which will receive Rs 467.55 crore this year, which is 27% more in comparison to the allocation of Rs 366.88 crore last year. The next in the row of...

-The Indian Express   Finance Minister Pranab Mukherjee today announced Rs 1,00,000 crore increase in the agriculture credit target to Rs 5,75,000 for the next fiscal and raised the outlay for farm sector by about Rs 3,000 crore. "Agriculture continues to be a priority to the government. The total plan outlay for agriculture and cooperation has been increased by 18 per cent from Rs 17,123 crore in 2011-12 to Rs 20,208 crore in...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...